Stem Cell Therapy May Work in Severe Myasthenia Gravis (CME/CE)
(MedPage Today) -- Small single-center study supports autologous stem cell transplant for severe myasthenia gravis (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - April 5, 2016 Category: Neurology Source Type: news
Study examines impact of 2 new antibodies in causing, treating myasthenia gravis
(Medical College of Georgia at Augusta University) A study of patients from across the nation with myasthenia gravis is helping determine the incidence of two new antibodies believed to cause the disease, and whether these patients need different treatment strategies. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 5, 2016 Category: Global & Universal Source Type: news
Catalyst Pharmaceuticals Receives "Refusal to File" Letter From the FDA on Its NDA for Firdapse
CORAL GABLES, Fla., Feb. 17, 2016 -- (Healthcare Sales & Marketing Network) -- Catalyst Pharmaceuticals, Inc. (CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases, tod... Biopharmaceuticals, FDACatalyst Pharmaceuticals, Firdapse, amifampridine, Lambert Eaton Myasthenic (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 17, 2016 Category: Pharmaceuticals Source Type: news
Lambert-Eaton Syndrome: Causes, Symptoms & Treatments
Lambert-Eaton syndrome also known as, 'Lambert-Eaton myasthenic syndrome,' is a condition in which a person's immune system attacks their neuromuscular junctions, the areas where your nerves and muscles connect. Usually a person's nerve cells pass signals along to their muscles. The signals help to make your muscles move. Due to the fact that Lambert-Eaton syndrome affects the way a person's nerves and muscles communicate, moving muscles becomes difficult. (Source: Disabled World)
Source: Disabled World - December 27, 2015 Category: Disability Tags: Autoimmune Diseases Source Type: news
Catalyst Pharmaceuticals Completes NDA Submission to FDA for Firdapse for the Treatment of Lambert-Eaton Myasthenic Syndrome and Congenital Myasthenic Syndromes
CORAL GABLES, Fla., Dec. 17, 2015 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases, announced... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - December 17, 2015 Category: Drugs & Pharmacology Source Type: news
ARJ Infusion Services, Lonnie Kersey Receives Prestigious Award from...
Myasthenia Gravis Association of Kansas City presented Lonnie Kersey the “Stackhouse Distinguished Service Award”. It's the organization's most prominent award of the year.(PRWeb November 12, 2015)Read the full story at http://www.prweb.com/releases/2015/11/prweb13075792.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - November 13, 2015 Category: Pharmaceuticals Source Type: news
Orphan Drug Shown Effective for LEMS WeaknessOrphan Drug Shown Effective for LEMS Weakness
The study was designed to finally earn FDA approval for 3,4 DAP, long used to treat Lambert-Eaton myasthenic syndrome on a compassionate basis. Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - October 7, 2015 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
FDA panel recommends limited use of Bayer’s Essure until more is known about safety
An FDA advisory panel yesterday recommended that the agency limit the use of Bayer‘s (ETR:BAYN) Essure female sterilization device until more is known about its safety, after thousands of women reported serious health issues they attribute to the nickel-titanium implant.
Essure, the only approved permanent birth control device in the U.S., is a small metal coil that is placed in the fallopian tubes via catheter. The FDA approved the device in November 2002.
In the near 13 years since then, the health regulator said it had received 5,093 complaints, including those of pain or menstrual irregularities after using th...
Source: Mass Device - September 25, 2015 Category: Medical Equipment Authors: Brad Perriello Tags: Food & Drug Administration (FDA) Regulatory/Compliance Women's Health Bayer HealthCare Obstetrics and Gynecology Devices Advisory Panel Source Type: news
The Emerging Role of Tacrolimus in Myasthenia GravisThe Emerging Role of Tacrolimus in Myasthenia Gravis
Is the immunosuppressive drug tacrolimus beneficial in reducing symptoms of myasthenia gravis? This review summarizes the latest evidence. Therapeutic Advances in Neurological Disorders (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 26, 2015 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news
Pediatric Patient Loses Spontaneous Respirations
Matthew, a 6-year-old male, has been feeling increasingly short of breath throughout the course of the morning. His father also notices that over the last several days he’s been appearing increasingly tired with a cough. Matthew is watching TV on the floor in the living room when his father enters the room and finds him unresponsive and apneic. He calls 9-1-1.
The Call
Paramedics respond immediately, but the response is uneventful. They arrive on scene and are met outside by the patient’s father, who takes them into the house and tells them his son has been feeling ill over the past several days but wasn’t given any ...
Source: JEMS Special Topics - March 11, 2015 Category: Emergency Medicine Authors: Elizabeth K. Powell, MD Tags: Airway & Respiratory Patient Care Source Type: news
Score in Development to Detect Myasthenia Gravis WorseningScore in Development to Detect Myasthenia Gravis Worsening
A scoring system can help predict the risk for conversion from ocular myasthenia gravis to generalized disease, a new study has shown. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 26, 2015 Category: Consumer Health News Tags: Ophthalmology News Source Type: news
New Diagnostic Test Proposed for Myasthenia GravisNew Diagnostic Test Proposed for Myasthenia Gravis
Ocular vestibular-evoked myogenic potentials could be used to diagnose myasthenia gravis, researchers report. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 25, 2015 Category: Consumer Health News Tags: Ophthalmology News Source Type: news
Myasthenia Gravis Therapeutic Pipeline Drugs and Companies Review H2...
RnRMarketResearch.com adds Myasthenia Gravis Pipeline Review H2 2014 to its store. The report provides an overview of the Myasthenia Gravis therapeutic pipeline.(PRWeb December 15, 2014)Read the full story at http://www.prweb.com/releases/2014-h2-myasthenia-gravis/pipeline-review-market/prweb12395670.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - December 16, 2014 Category: Pharmaceuticals Source Type: news
